Computerized Extraction of Electrocardiograms From Continuous 12‐Lead Holter Recordings Reduces Measurement Variability in a Thorough QT Study

Continuous Holter recordings are often used in thorough QT studies (TQTS), with multiple 10‐second electrocardiograms (ECGs) visually selected around predesignated time points. The authors hypothesized that computer‐automated ECG selection would reduce within‐subject variability, improve study data precision, and increase study power. Using the moxifloxacin and placebo arms of a Holter‐based crossover TQTS, the authors compared interval duration measurements (IDMs) from manually selected to computer‐selected ECGs. All IDMs were made with a fully automated computer algorithm. Moxifloxacin‐induced changes in baseline‐ and placebo‐subtracted QT intervals were similar for manual and computer ECG selection. Mean 90% confidence intervals were narrower, and within‐subject variability by mixed‐model covariance was lower for computer‐selected than for manual‐selected ECGs. Computer ECG selection reduced the number of subjects needed to achieve 80% power by 40% to 50% over manual. Computer ECG selection returns accurate ddQTcF values with less measurement variability than manual ECG selection by a variety of metrics. This results in increased study power and reduces the number of subjects needed to achieve desired power, which represents a significant potential source cost savings in clinical drug trials.

[1]  Joanne Zhang Testing for Positive Control Activity in a Thorough QTc Study , 2008, Journal of biopharmaceutical statistics.

[2]  A. Beckett,et al.  AKUFO AND IBARAPA. , 1965, Lancet.

[3]  P. Kowey,et al.  Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects. , 2009, Journal of electrocardiology.

[4]  Alex Dmitrienko,et al.  Sample Size Calculations in Thorough QT Studies , 2008, Journal of biopharmaceutical statistics.

[5]  Borje Darpo,et al.  Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods , 2004, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[6]  B. Tyl,et al.  Comparison of Semiautomated and Fully Automated Methods for QT Measurement During a Thorough QT/QTc Study: Variability and Sample Size Considerations , 2009, Journal of clinical pharmacology.

[7]  B. Darpo,et al.  Comparison of Manual and Automated Measurements of the QT Interval in Healthy Volunteers: An Analysis of Five Thorough QT Studies , 2009, Clinical pharmacology and therapeutics.

[8]  Charles Ho,et al.  Advances in ambulatory monitoring: regulatory considerations. , 2004, Journal of electrocardiology.

[9]  Stella G. Machado,et al.  Statistical Issues Including Design and Sample Size Calculation in Thorough QT/QTc Studies , 2008, Journal of biopharmaceutical statistics.

[10]  Joel Morganroth,et al.  A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment. , 2004, Journal of electrocardiology.

[11]  J. Ruskin,et al.  The combined use of ibutilide as an active control with intensive electrocardiographic sampling and signal averaging as a sensitive method to assess the effects of tadalafil on the human QT interval. , 2005, Journal of the American College of Cardiology.

[12]  F. Badilini,et al.  Implications of methodological differences in digital electrocardiogram interval measurement. , 2006, Journal of electrocardiology.

[13]  Borje Darpo,et al.  THEMED SECTION: QT SAFETY REVIEW The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance , 2010 .

[14]  D. Altman,et al.  Measuring agreement in method comparison studies , 1999, Statistical methods in medical research.

[15]  D. Karnad,et al.  Effect of Number of Replicate Electrocardiograms Recorded at Each Time Point in a Thorough QT Study on Sample Size and Study Cost , 2011, Journal of clinical pharmacology.

[16]  Automatic Extraction of ECG Strips from Continuous 12‐lead Holter Recordings for QT Analysis at Prescheduled versus Optimized Time Points , 2009, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[17]  G. Koch,et al.  Sample Size Calculations for Crossover Thorough QT Studies: Satisfaction of Regulatory Threshold and Assay Sensitivity , 2010, Journal of biopharmaceutical statistics.

[18]  J M Bland,et al.  Statistical methods for assessing agreement between two methods of clinical measurement , 1986 .

[19]  Lawrence J Hickey,et al.  The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT Studies , 2008, Clinical pharmacology and therapeutics.

[20]  H. Lepor,et al.  Effects of the Selective α1A‐Adrenoceptor Antagonist Silodosin on ECGs of Healthy Men in a Randomized, Double‐Blind, Placebo‐ and Moxifloxacin‐Controlled Study , 2010, Clinical pharmacology and therapeutics.

[21]  B. Tyl,et al.  Detection of Clinically Significant QTc Prolongation in Phase I Studies in Healthy Participants: Comparison of 2 Semiautomated QT Measurement Methods , 2009, Journal of clinical pharmacology.

[22]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[23]  S. Rohatagi,et al.  Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs , 2009, Journal of clinical pharmacology.